{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-003301","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.461830+00:00","generated_at":"2026-05-15T06:47:16.768315+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"medium","headline":"ZEO signs MOU to be exclusive biologics supplier for Regen Therapy's 3,000-clinic network","bullets":["MOU positions ZEO as core supplier of advanced biologic therapeutics for Regen Therapy's regenerative platform.","Regen Therapy's network includes over 3,000 clinics and 24,000 practitioners across the U.S.","Regen also partnered with Stealth Health for white-label telemedicine and longevity services.","No financial terms or binding agreement disclosed; MOU is non-definitive.","ZEO's expertise in extracellular vesicle and perinatal-derived therapeutics to support next-gen products."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-003301","json":"https://secwatch.observer/filing/0001829126-26-003301.json","markdown":"https://secwatch.observer/filing/0001829126-26-003301.md","text":"https://secwatch.observer/filing/0001829126-26-003301.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626003301/0001829126-26-003301-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912626003301/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:47:16.768315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}